Alfredo Guerra - Grifols SA CFO and Corporate VP

GIKLY Stock  USD 5.05  0.51  9.17%   

CFO

Alfredo Guerra is CFO and Corporate VP of Grifols SA ADR since 2014.
Age 65
Tenure 10 years
Phone34 93 571 02 21
Webhttps://www.grifols.com

Grifols SA Management Efficiency

The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.
Grifols SA ADR has accumulated 6.1 B in total debt with debt to equity ratio (D/E) of 1.14, which is about average as compared to similar companies. Grifols SA ADR has a current ratio of 2.63, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Grifols SA until it has trouble settling it off, either with new capital or with free cash flow. So, Grifols SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grifols SA ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grifols to invest in growth at high rates of return. When we think about Grifols SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CFO Age

Lucas MontarceEli Lilly and
47
Joseph CPAJohnson Johnson
57
Peter GriffithAmgen Inc
65
Matthew WalshOrganon Co
57
Scott ReentsAbbVie Inc
56
Michael CPABiogen Inc
60
Matthew CFAOrganon Co
57
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 27584 people. Grifols SA ADR [GIKLY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Grifols SA ADR Leadership Team

Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nuria Lapea, Risk Treasury
Maria Llano, Chief Officer
M Tubau, Co Affairs
Steven JD, Ex Chairman
Mateo Humbert, Director of Human Resources
Montserrat Llamas, Chief Officer
Vctor Deu, CoCEO Director
Alfredo Guerra, CFO and Corporate VP
Raimon Roura, Non-Member Secretary of the Board
David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries

Grifols Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Grifols Pink Sheet Analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.